Key statistics
On Friday, Immunic Inc (IMUX:NSQ) closed at 1.18, 24.85% above the 52 week low of 0.9451 set on Nov 13, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.21 |
---|---|
High | 1.22 |
Low | 1.16 |
Bid | 1.18 |
Offer | 1.24 |
Previous close | 1.18 |
Average volume | 821.44k |
---|---|
Shares outstanding | 90.08m |
Free float | 87.07m |
P/E (TTM) | -- |
Market cap | 106.29m USD |
EPS (TTM) | -1.51 USD |
Data delayed at least 15 minutes, as of Nov 08 2024 21:00 GMT.
More ▼
- EQS-News: Immunic, Inc. Reports Third Quarter 2024 Financial Results and Provides Corporate Update
- EQS-News: Immunic, Inc. to Announce Financial Results for the Third Quarter Ended September 30, 2024, and Provide Corporate Update
- EQS-News: Immunic to Participate in Industry, Scientific and Investor Conferences in November
- EQS-News: Immunic Announces Positive Outcome of Interim Analysis of Phase 3 ENSURE Program of Vidofludimus Calcium in Relapsing Multiple Sclerosis
- EQS-News: Immunic Presents Key Vidofludimus Calcium Data at the 40th Congress of ECTRIMS, Highlighting Its Therapeutic Potential in Multiple Sclerosis
- EQS-News: Immunic Announces First Patient Enrolled in Investigator-Sponsored Phase 2 Clinical Trial of Vidofludimus Calcium in Patients with Post COVID Syndrome
- EQS-News: Immunic to Host Multiple Sclerosis R&D Day and Participate in Scientific and Investor Conferences in September
More ▼